[EN] COMPLEXES OF CU(I) AS ANTITUMOR AGENTS<br/>[FR] COMPLEXES DU CU (I) UTILISÉS COMME AGENTS ANTITUMORAUX
申请人:UNIV DEGLI STUDI PADOVA
公开号:WO2022263556A1
公开(公告)日:2022-12-22
The invention relates to a Cu(l) complex of Formula (I), wherein L is a ligand of Formula (II), wherein n1, n2, n3 are independently to each other, an integer from 0 to 1, A1, A2 and A3 are independently from each other,- a phenyl optionally substituted with (C1-C3)alkoxy, (C1-C3)alkyl, F, formyl, carboxyl, sulphonyl hydroxyl, hydroxyl, methoxy(C1-C3)alkoxy or - an heterocyclic ring selected from piperazinyl, morpholynyl, thiomorpholynyl, optionally substituted with (C1-C3)alkyl, where the heterocyclic ring is linked with the nitrogen atom to -CH2- residue, with the proviso that when A1, A2 or A3 is optionally substituted phenyl, then n1, n2 or n3, respectively, is 0, and when A1, A2 or A3 is optionally substituted heterocyclic ring, then n1, n2 or n3, respectively, is 1, for use in the treatment of tumours.
本发明涉及一种公式(I)的Cu(l)配合物,其中L是公式(II)的配体,其中n1,n2,n3彼此独立地是0到1的整数,A1,A2和A3彼此独立地是-苯基(可选地取代(C1-C3)烷氧基,(C1-C3)烷基,F,甲酰基,羧基,磺酰基,羟基,羟基,甲氧基(C1-C3)烷氧基或-从哪种异环戊二氮基,吗啉基,硫代吗啉基,可选地取代(C1-C3)烷基的杂环环,其中杂环环与氮原子连接到-CH2-残基,但是当A1,A2或A3是可选取代的苯基时,n1,n2或n3分别为0,当A1,A2或A3是可选取代的杂环环时,n1,n2或n3分别为1,用于治疗肿瘤。